A 34-year-old pregnant patient at 33 weeks' gestation presents in September. To reduce RSV risk in her newborn, current guidance recommends which prevention strategy?AOne dose of maternal RSV vaccine (Abrysvo) at 32-36 weeks' gestation during the RSV seasonBAdminister infant palivizumab to the newborn regardless of riskCGive maternal mRNA RSV vaccine at any time in pregnancyDDefer any RSV prevention until 2 months after birthEStart maternal RSV vaccine in the first trimester for maximal antibody transferCheck my answer